These drugs include Antidepressants / selective serotonin - norepinephrine reuptake inhibitors Another antipsychotic Lithium Benzodiazepines Investigational new drugs that antagonize the dopamine receptor are under development, including ABT-925, BL1020, ITI 007, JNJ-37822681, and other novel drugs (2).